Necrotizing Thrombophlebitis Secondary to Mycobacterium Chelonae in a Hemodialyzed Patient

Am J Dermatopathol. 2017 Jun;39(6):487-489. doi: 10.1097/DAD.0000000000000684.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Amikacin / therapeutic use
  • Anti-Bacterial Agents / therapeutic use
  • Biopsy, Needle
  • Clarithromycin / therapeutic use
  • Drug Therapy, Combination
  • Humans
  • Immunohistochemistry
  • Kidney Failure, Chronic / diagnosis
  • Kidney Failure, Chronic / therapy
  • Male
  • Mycobacterium Infections, Nontuberculous / diagnosis*
  • Mycobacterium Infections, Nontuberculous / drug therapy
  • Mycobacterium chelonae / drug effects
  • Mycobacterium chelonae / isolation & purification*
  • Necrosis / pathology
  • Prognosis
  • Renal Dialysis / adverse effects*
  • Renal Dialysis / methods
  • Severity of Illness Index
  • Thrombophlebitis / drug therapy
  • Thrombophlebitis / etiology
  • Thrombophlebitis / microbiology*
  • Thrombophlebitis / pathology
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Amikacin
  • Clarithromycin